A silent outbreak due to Klebsiella pneumoniae that co-produced NDM-1 and OXA-48 carbapenemases, and infection control measures

Objective(s): Infections due to carbapenemase-producing Klebsiella pneumoniae are associated with high morbidity and mortality. In this study, we report a hospital outbreak due to co-producing OXA-48 and NDM-1 K. pneumoniae clone. The aim of the study is to investigate the clonal relationship of strains, risk factors of outbreak and infection control measures. Materials and Methods: Once an outbreak was suspected at the end of December 2017 in our intensive care unit (ICU), carbapenem resistance K. pneumoniae identified in patients’ specimens. An outbreak analysis was begun to determine the risk factors and dissemination of the cases. A case-control study was conducted to determine the risk factors. To control the outbreak; tight contact prevention, good clean-up the medical devices and hospital environment, were done. Staff training programs such as hand hygiene, disinfection, wearing aprons, good cleaning were created. Carbapenem resistance genes determined by PCR. Clonal relationships of strains investigated by PFGE. Results: We investigate 21 carbapenem-resistant K. pneumonia strains. Nine of them were found co-produced NDM-1 and OXA-48, 11 strains produced OXA-48, and one strain produced NDM-1. Seven strains of co-producing NDM-1 and OXA-48 were found clonally related with PFGE. We could not determine any risk factor except rectal colonization in the case-control study. Conclusion: The interventions that successfully controlled this outbreak were hand hygiene, tight contact prevention, good clean-up of the hospital environment and medical devices. As a result, we believe that it would be beneficial to take infection control measures to prevent the spread of these strains to the community and hospital settings.

[1]  M. Parlak,et al.  Hospital Outbreak of a Colistin-Resistant, NDM-1- and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance. , 2018, Microbial drug resistance.

[2]  R. Wunderink,et al.  Carbapenem-Resistant Enterobacteriaceae Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical Trials , 2017, Open forum infectious diseases.

[3]  Young Bae Kim,et al.  Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods , 2016, Front. Microbiol..

[4]  W. Hryniewicz,et al.  Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[5]  J. Lavigne,et al.  Environmental persistence of OXA-48-producing Klebsiella pneumoniae in a French intensive care unit. , 2016, American journal of infection control.

[6]  A. Kilic,et al.  The First Klebsiella pneumoniae Isolate Co-Producing OXA-48 and NDM-1 in Turkey , 2015, Annals of laboratory medicine.

[7]  B. Wiedenmann,et al.  An outbreak of carbapenem-resistant OXA-48 – producing Klebsiella pneumonia associated to duodenoscopy , 2015, Antimicrobial Resistance and Infection Control.

[8]  P. Nordmann,et al.  The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  S. Solomon,et al.  Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.

[10]  D. Raoult,et al.  New Delhi Metallo-beta-lactamase around the world: an eReview using Google Maps. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  P. Nordmann,et al.  Spread of NDM-1-Producing Enterobacteriaceae in a Neonatal Intensive Care Unit in Istanbul, Turkey , 2014, Antimicrobial Agents and Chemotherapy.

[12]  M. Timinouni,et al.  First report of a Klebsiella pneumoniae strain coproducing NDM‐1, VIM‐1 and OXA‐48 carbapenemases isolated in Morocco , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[13]  M. Bassetti,et al.  Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  R. Widen,et al.  Rapid detection of carbapenemase genes by multiplex real-time PCR. , 2012, The Journal of antimicrobial chemotherapy.

[15]  Thierry Naas,et al.  Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.

[16]  Clinical,et al.  Performance standard for antimicrobial susceptibility testing. , 2010 .

[17]  A. Tekeli,et al.  [Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae strains isolated between 2004-2007 in Ankara University Hospital, Turkey]. , 2010, Mikrobiyoloji bulteni.

[18]  B. Otlu,et al.  The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. , 2009, Japanese journal of infectious diseases.

[19]  Iraida E. Robledo,et al.  Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. , 2009, MMWR. Morbidity and mortality weekly report.

[20]  P. Nordmann,et al.  Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey , 2008, Antimicrobial Agents and Chemotherapy.

[21]  Z. Aktaş,et al.  Carbapenem-Hydrolyzing Oxacillinase, OXA-48, Persists in Klebsiella pneumoniae in Istanbul, Turkey , 2008, Chemotherapy.

[22]  F. Biscione,et al.  A 10-year prospective surveillance of nosocomial infections in neonatal intensive care units. , 2007, American journal of infection control.

[23]  N. Woodford,et al.  Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. , 2006, The Journal of antimicrobial chemotherapy.

[24]  P. Nordmann,et al.  Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae , 2004, Antimicrobial Agents and Chemotherapy.